Call for Abstract

2nd World Congress on Rare Diseases, will be organized around the theme “The Future of Drug Development for Rare Diseases”

World Rare Diseases 2020 is comprised of keynote and speakers sessions on latest cutting edge research designed to offer comprehensive global discussions that address current issues in World Rare Diseases 2020

Submit your abstract to any of the mentioned tracks.

Register now for the conference by choosing an appropriate package suitable to you.

rare disease is the disease which affects a small proportion of the population. Symptoms do not appear immediately and most rare diseases are genetic and thus are present throughout the person's entire life. Many rare diseases appear early in life, and about 30% of children with rare diseases will die before reaching their five years. Rare diseases may be chronic or sometimes incurable. A short term medical condition also comes under Rare Diseases. The rarest known genetic disease is caused by ribose-5-phosphate isomerase deficiency. Rare diseases may be result from:

 

  • Track 1-1Bacterial or viral infections
  • Track 1-2Allergies
  • Track 1-3 Chromosome disorders affecting any body organ.

Orphan drugs are the medicinal products used to treat rare diseases or rare disorders and intended for the treatment, prevention or diagnosis of a rare disease or condition Because of their limited market they are called “orphan drugs”. An orphan disease is defined as that affects less than 200,000 people nationwide. Most of the orphan diseases are with a genetic basis. One out of 15 persons worldwide could be affected by orphan disease. 

 

  • Track 2-1Cystic fibrosis
  • Track 2-2Wilson’s disease

Infectious diseases mainly caused by bacteria, viruses, fungi or parasites. Many organisms live in and on our bodies. They are generally harmless or sometimes helpful. But under some conditions, organisms may cause disease. An infectious disease is also known as a transmissible disease or communicable disease that results from an infection. Infectious diseases when easily transmitted by contact with an ill person then they are called as contagious diseases.

 

  • Track 3-1Acanthamoeba keratitis.
  • Track 3-2Scarlet fever

Rare genetic diseases are caused by one or more abnormalities in the genome. It may be caused due to mutation in a single gene or multiple genes. However, there are no known treatments for genetic disorders. Many genetic disorders influence stages of development like Down syndrome, while others result in physical symptoms such as muscular dystrophy. Due to the wide range of genetic disorders, diagnosis is widely varied and depending on the disorder. Gene therapy refers to one of the treatment where a healthy gene is introduced to a patient. This should reduce the defect caused by a faulty gene or slow the progression of the disease.

 

  • Track 4-1Albinism
  • Track 4-2Angelman syndrome

Rare diseases which affect children are called Rare Pediatric diseases; the causes for pediatric diseases may be different from one another. Some of the rare pediatric diseases are Congenital Heart Defects, Schnitzler Syndrome, Eisenmenger Syndrome, Agammaglobulinemia, Pediatric Severe Combined Immunodeficiency and Kawasaki Disease

 

  • Track 5-1Pediatric bruton agammaglobulinemia
  • Track 5-2Pediatric severe combined immunodeficiency

Dermatology is the branch of medicine that deals with the skin problems. It involves both medical and surgical aspects. Dermatological Diseases includes common skin rashes to severe skin infections, which may occurs due to several things, such as infections, heat, allergens, system disorders and medications. Some rare skin diseases are

 

  • Track 6-1Inverse psoriasis
  • Track 6-2Harlequin ichthyosis

The branch of medicine concerned with the study of the cause, treatment and prevention of diseases related to blood is called haematology. The diseases or disorders which predominately affect the blood & blood-forming organs are called haematological diseases which include rare genetic disorders disease and complications from chemotherapy or transfusions. Some rare haematological diseases are:

 

  • Track 7-1Myelofibrosis
  • Track 7-2Polycythemia vera
  • Track 7-3Aplastic anemia

Most of the rare diseases are having genetic origin. In divergence rare cancers are mainly acquired diseases. Multiple division of cells, leading to the formation of malignant tumour is called Cancer. There are various types of cancer, some of the rare cancer diseases are:

 

  • Track 8-1Angiosarcoma
  • Track 8-2Alveolar soft part sarcoma
  • Track 8-3Chondrosarcoma

Progeria is an extremely rare genetic disorder in which symptoms having similar resemblance with respect to aging. People with progeria typically live between mid-teens to early twenties. It is a genetic condition which occurs as a new mutation, and is often inherited. The term progeria is related to all diseases characterized by premature aging symptoms. The premature symptoms may include:

  • Track 9-1Failure to thrive
  • Track 9-2localized scleroderma-like skin condition
  • Track 9-3Kidney failure

Brain diseases are mainly related to modification of brain function or structure. This is mainly due to infection, tumour and stroke, memory loss, personality change and seizures. Creutzfeldt-Jakob disease (CJD) is one of the rare degenerative brain disorder distinguished by development of rapidly progressive neurological and neuromuscular symptoms. After the onset of symptoms, affected people may develop confusion, depression, behavioral changes, impaired vision, and/or impaired coordination. As the disease progresses it results in vascular dementia, resulting in confusion and disorientation. Later stages of the disease may result in further loss of physical and intellectual functions like unconsciousness and infections of the respiratory tract like pneumonia.

  • Track 10-1Gerstmann-Straussler-Scheinker disease
  • Track 10-2Amyotrophic lateral sclerosis
  • Track 10-3Creutzfeldt-jakob disease

The study related to endocrine system is endocrinology, endocrine system that controls hormones. Rare metabolic disorders are mainly caused due to imbalance in endocrine system and its related hormones. Treatment of rare endocrine disorder is include specific symptoms that are perceptible in each individual and include surgery and drugs to counteract the disorders. Certain therapeutic procedures and arbitrations may vary depending upon particular disease. In most of the cases, there is no approved treatment for many rare endocrine diseases. In many cases, treatment is targeted towards specific symptoms.

  • Track 11-1Acromegaly
  • Track 11-2Thrombotic
  • Track 11-3Genetic disorders of RBC metabolism

The gastrointestinal diseases are those which affect the GI tract including colon and rectum. One of the rare diseases is Menetrier disease which is characterized by massive overgrowth of mucous cells in the mucous membrane that lines the stomach, resulting in large gastric folds. The symptoms associated with Menetrier disease is pain in the upper middle region of the stomach. Less frequent symptoms include nausea, vomiting, and diarrhoea. In some cases, weight reduction and loss of appetite may also occur. The cause of Menetrier disease is unknown. There will be minimal or no stomach inflammation in Menetrier disease.

  • Track 12-1Nausea and Vomiting
  • Track 12-2Diarrhoea
  • Track 12-3Weight reduction and loss of appetite may also occur

Immune system involves collection of structures and processes within the body to protect against disease or foreign bodies. Immune disease is a dysfunction of immune system. During its proper functioning, the immune system identifies a variance of threats including viruses, bacteria and parasites and discriminate them from the body's own healthy tissue. Allergic diseases such as allergic rhinitis, asthma and eczema are common immune diseases. Rare immune diseases include:

  • Track 13-1Celiac diseases
  • Track 13-2Rare diseases

Rare autoimmune diseases are those which affect body's immune system and attacks healthy cells. An autoimmune disease is a condition that emerges from an abnormal immune response to a normal body part and any body part can be involved. Immune system release proteins called autoantibodies which strike healthy cells. Common symptoms include low-grade fever, feeling tired, fatigue, skin infections and swelling. Symptoms may often come and go. The period when the symptoms go away is called remission.

 

  • Track 14-1Autoimmune poly-glandular syndrome
  • Track 14-2Severe combined immunodeficiency
  • Track 14-3Familial Mediterranean fever
  • Track 14-4Diabetes

There are approximately 7,000 rare diseases. Such rare diseases generally have a genetic basis, frequently affecting patients in childhood, and are often progressive and life threatening in nature. These characteristics can have highly destructive psychological impact on children suffering from these diseases. The major challenge for R&D is to look after the impact of unique characteristics of the rare disease patients on clinical development process and the interface between clinical development and the regulatory process. A fundamental challenge in drug development for rare diseases is that there is relatively little known about the pathophysiology of disease. In addition to these challenges, for most of the rare diseases there are no available therapies.

 

  • Track 15-1Patient attrition
  • Track 15-2Interface between clinical development and the regulatory process
  • Track 15-3Less knowledge on pathophysiology of disease

Clinical investigators in rare disease research regularly face challenges distinct to the study of uncommon disorders. Rare diseases often provide opportunities to study human physiology and biomedical science from distinctive perspectives. It is estimated that over 7000 rare diseases affect an estimated 25-30 million people with a rare disease (8-12% of population). The Orphan Drug Act was approved in 1983 to provide funds that encourage developing optimistic drugs to treat, prevent, or diagnose rare diseases or conditions affecting less than 200,000 persons. The scientific methodology and logistics of clinical research for rare diseases have changed drastically in the past two decades. Understanding pathophysiology of the disease has been increased and many new treatments have been developed.

  • Track 16-1Orphan products clinical Trials Grants Program
  • Track 16-2Research on new drugs
  • Track 16-3Biomedical

Gene therapy is one of the logical ways to treat rare genetic disorders; restore a single gene defect by introducing a 'correct' gene as 80% of the rare diseases are caused by single gene and gene therapy has the potential to cure cardinal genetic defects. Additionally, successful gene therapy may require single dose for the lifelong improvement. Using of antisense therapeutics is another way of treating rare diseases and it is a RNA based drug delivery. Cell therapy is the other technique for treating rare diseases where viable cells are injected into the patient for medicinal effect.

 

  • Track 17-1Rexin G
  • Track 17-2Carmustine
  • Track 17-3Nanotechnology and Nano-medicine

Over 6000 different rare diseases have been identified till date, affecting the daily life of more than 30 million people. The complex nature of rare diseases, accompany with limited approach to treatment and services. Many rare diseases have no cure, so living with a rare disease is an ongoing learning process for patients and families. Typically life threatening, chronic and debilitating, rare diseases have enormous consequences for the whole family. Though the names of the disease and symptoms may be different but rare diseases impact the daily lives of patients and families in close ways.

  • Track 18-1Find a diagnosis
  • Track 18-2Access the treatment

Rare diseases affect almost 2-4% of the population. It mainly affects children between the age of 3-5 years. Mystery diagnosis for rare diseases is whole genome sequencing, as 80% of the rare diseases are genetic in nature thus genome sequencing based diagnosis provides an optimistic alternative foe rare disease management. Genome sequencing can be used for rare and undiagnosed disease research to locate causative variants of inherited disorders by assessing many genes yielding a diagnostic rate of 62.5%.

 

  • Track 19-1Mystery illness program
  • Track 19-2Rarity of the condition or disease

The rare diseases research had reached a critical phase. The diseases could be diagnosed, and new treatments were successfully evolved and approved, and improvements in quantity and quality of life achieved. It is still a reality for rare disease patients to spend a long time within the health care system before an exact conclusion is made. Research in rare infectious diseases are crucial as many patients still need proper diagnosis and left without compelling medications; it is also a region where expertise is also rare. In addition, research in this region is exceptionally significant from the scientific point of view as rare diseases are model diseases for more common disorders and are strong drivers of innovation diagnostics.

  • Track 20-1Diagnostics
  • Track 20-2Therapeutic discovery challenges

Case Report is a detailed report of various symptoms, signs, diagnosis and treatment, and also a follow-up of an individual patient.  Major scientific breakthroughs ensuing from investigation of rare diseases have usually provided insight into a lot of common disorders. The satisfaction of diagnosis a patient with a rare disorder with success is commonly chop-chop countered by the conclusion that the flexibility to know and treat the patient’s condition is restricted by mental object and also the difficulties of finding out the malady. Maybe the foremost frequent downside is that the enlisting of a requisite variety of study subjects for Associate in Nursing data-based cohort or a run. This would like needs the creation of multi-institutional and international collaborations to conduct clinical investigation in rare diseases.

  • Track 21-1Therapeutic discovery challenges
  • Track 21-2Researchers case reports